We
combine our passion, expertise, and transformative technology to stop preventable death by bleeding and save lives across the world.
Velico is a private, clinical stage medical technology company headquartered in Beverly, Massachusetts. We are committed to the mission of reducing preventable death from bleeding.
We are developing a novel, spray dried plasma manufacturing system that will equip blood centers around the world to produce spray dried plasma products for transfusion. FrontlineODP™ (On Demand Plasma) rehydrates in minutes at the point of medical care making it ideal for early, pre-hospital use on ground and air ambulances, in military settings, and for mass casualty events.
For over 20 years, Velico has been focused on developing innovative blood and plasma products for transfusion. We have focused our efforts on improving the usability, accessibility, and shelf life of specialized blood products.
We have developed a broad portfolio of patents to protect our inventions. Our investment in talented people, intentional collaborations, innovative engineering and novel technology developments will yield products which will improve access to blood and save countless lives around the world upon release of our first product, FrontlineODP™. This, and the products that follow, will be vital to the future of blood.
Richard Meehan
President, CEO and Chairman
A message from Richard
Introducing FrontlineODP™
Preventable death from hemorrhage following trauma is a global concern which has been targeted by trauma surgeons, emergency medical providers, mass casualty planners, the military and national governments as a top priority. Velico is proud to be developing the FrontlineODP™ Spray Dried Plasma System in support of this call to action.
FrontlineODP™ is a spray dried plasma unit designed for rapid rehydration, intended to support the management of traumatic hemorrhage in situations where conventional plasma is unavailable or impractical. This includes pre-hospital transfusions, rural and austere healthcare settings, and military applications.
Spray Dried Plasma
This is our innovative solution…
Efficient. Scalable. Reliable.
In just over 30 minutes, the FrontlineODP™ Spray Dried Plasma System transforms one unit of plasma into a shelf stable, readyto-use spray dried plasma product. With a single FrontlineODP™ System, you can produce up to 9,000 units annually.
The FrontlineODP™ Spray Dried Plasma System is being designed for easy integration in blood center component laboratories. Decentralized production by blood centers will aim to take advantage of blood component manufacturing expertise and product supply chains, from established volunteer blood donor bases to end user distribution including emergency logistics channels.
Decentralized production sets the stage for local spray dried plasma self-sufficiency and national emergency preparedness including civilian, government and military collaboration for strategic stockpiles and readiness for major mass casualty events.
Watch how the FrontlineODP™ Spray Dried Plasma System works
Why is it needed?
30-40 percent of deaths from bleeding are considered preventable. In the United States preventable death from bleeding takes over 30,000 lives per year with over 100,000 more estimated throughout the rest of the world † .
During World War II, over 10 million Units of dried plasma were produced to satisfy demand. Current global production capacity is less than 30,000 units, falling far short of today’s military and civilian demand.
A spray dried plasma solution will potentially allow for new methods of blood product distribution throughout the EMT community. The potential longevity of Spray Dried Plasma
Our Production Models
means that emergency vehicles may be able to carry this product for longer than whole blood or other alternatives without replenishing as often.
In addition, as spray dried plasma is being designed to be stored in ambient conditions, it has the potential to save more lives, especially where emergency vehicles do not have appropriate refrigerated facilities but could provide ambient controlled temperature storage conditions.
† Cannon JW. Hemorrhagic shock. N Engl J Med. 2018 Jan 25;378(4):370-9
Velico delivers the highest-output dried plasma production solution on the planet - unmatched in scalability and built to secure sovereign blood supply chain independence.
Scan to read more about our veliPod solutions
Velico has engineered two flexible production models for its groundbreaking FrontlineODP™ Spray Dried Plasma System, each designed to meet the evolving needs of modern blood operations. The first model is the veliPod - a modular, self-contained laboratory built within the compact footprint of a standard shipping container. Transportable and customizable to specific requirements, the veliPod offers a rapid, scalable solution for establishing spray dried plasma production anywhere it’s needed.
Our second model offers a fixed installation that integrates seamlessly into existing blood component laboratories with no specialized processing environments or clean rooms required. Designed to streamline workflows, it boosts both efficiency and responsiveness in plasma processing operations.
FrontlineODPTM Business Model
Rehydration
The FrontlineODP™ unit is easily rehydrated in two and a half minutes with 200ml of sterile water (SWFI), making it practical in prehospital and hospital settings (i.e. rural) where fresh plasma is unavailable.
Watch how easily The FrontlineODPTM spray dried plasma rehydrates
Manufactures Systems/Consumables
• Sells Systems/Consumables to Blood Centers
• Sells Field Service to Regional Blood Centers
• Sells to Customers
• Potential Site for Strategic Stockpiles
FrontlineODP™ (On Demand Plasma) Intended Use
FrontlineODPTM has the potential to revolutionize emergency and prehospital care by:
• Expanding plasma accessibility for ground and air EMS teams
• Enhancing availability in rural and underserved areas
• Providing battlefield-ready plasma solutions for military use
• Strengthening mass casualty preparedness with regional stockpiles
Transfusion
Uncontrolled hemorrhage is recognized as the leading cause of preventable death among victims of trauma. The early administration of plasma has been demonstrated to be lifesaving for many of these patients †
† Sperry JL, et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326
&
First Responders in other Austere Locations Hospitals
For more information please contact:
Richard Meehan, President & CEO
US: +1 (978) 338 4590
EU: +353 (86) 020 9272
rmeehan@veli.co
Andre Cap, Chief Scientific Officer
US: +1 (210) 410 6882
acap@veli.co
US
100 Cummings Center # 436H, Beverly, MA 01915, United States +1 978 232 8370
Europe
5 Clarendon Mews, Lad Lane, Dublin 2, Ireland, D02 EE61 +353 1 2500 055
